Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Osteoporos Int ; 31(11): 2251-2257, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32572521

RESUMEN

Using genetic, clinical, biochemical, and radiographic assessment and bioinformatic approaches, we present an unusual case of adult HPP caused by a novel de novo heterozygous nonsense mutation in the alkaline phosphatase (ALPL). INTRODUCTION: Hypophosphatasia (HPP) is caused by genetic alterations of the ALPL gene, encoding the tissue-nonspecific isozyme of alkaline phosphatase (TNSALP). Here, the purpose was to perform clinical and molecular investigation in a 36-year-old Caucasian woman suspected to present adult HPP. METHODS: Medical and dental histories were obtained for the proposita and family members, including biochemical, radiographic, and dental assessments. ALPL mutational analysis was performed by the Sanger sequencing method, and the functional impact prediction of the identified mutations was assessed by bioinformatic methods. RESULTS: We identified a novel heterozygous nonsense mutation in the ALPL gene (NM_000478.6:c.768G>A; W[TGG]>*[TGA]) associated with spontaneous vertebral fracture, severe back pain, musculoskeletal pain, low bone density, and short-rooted permanent teeth loss. Functional prediction analysis revealed that the Trp256Ter mutation led to a complete loss of TNSALP crown domain and extensive loss of other functional domains (calcium-binding domain, active site vicinity, and zinc-binding site) and over 60% loss of homodimer interface residues, suggesting that the mutant TNSALP molecules are nonfunctional and form unstable homodimers. Genotyping of the ALPL in the proposita's parents, sister, and niece revealed that in this case, HPP occurred due to a de novo mutation. CONCLUSION: The present study describes a novel genotype-phenotype and structure-function relationship for HPP, contributing to a better molecular comprehension of HPP etiology and pathophysiology.


Asunto(s)
Fosfatasa Alcalina , Hipofosfatasia , Adulto , Fosfatasa Alcalina/genética , Codón sin Sentido , Análisis Mutacional de ADN , Femenino , Heterocigoto , Humanos , Hipofosfatasia/diagnóstico por imagen , Hipofosfatasia/genética , Mutación
2.
J Dent Res ; 83(8): 602-7, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15271967

RESUMEN

Lipopolysaccharides are potent inflammatory mediators considered to contribute to destruction of periodontal tissues. Here, we hypothesized that Porphyromonas gingivalis lipopolysaccharide (P-LPS) treatment would regulate gene expression in murine cementoblasts through Toll-like receptor 4. Real-time (RT)-PCR and Northern blot analysis indicated that P-LPS decreased expression of transcripts for osteocalcin (OCN) and receptor activator of nuclear factor kappaB ligand (RANKL). In contrast, a dose-dependent up-regulation in mRNA levels for osteopontin (OPN) and osteoprotegerin (OPG) was observed. Similarly, ELISA demonstrated decreased RANKL and increased OPG levels. A monoclonal antibody specific for mouse TLR-4/MD-2 partially neutralized the P-LPS effect on cementoblasts. These results indicate that exposure of cementoblasts to P-LPS can alter cell function by regulating markers of osteoclastic activity (e.g., RANKL/OPG), thereby potentially affecting the inflammation-associated resorption of mineralized tissues.


Asunto(s)
Antígenos Ly/metabolismo , Cemento Dental/efectos de los fármacos , Lipopolisacáridos/farmacología , Glicoproteínas de Membrana/metabolismo , Porphyromonas gingivalis , Receptores de Superficie Celular/metabolismo , Animales , Antígenos Ly/efectos de los fármacos , Antígenos Ly/genética , Northern Blotting , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Células Cultivadas , Cemento Dental/citología , Cemento Dental/metabolismo , Relación Dosis-Respuesta a Droga , Regulación de la Expresión Génica/efectos de los fármacos , Glicoproteínas/genética , Glicoproteínas/metabolismo , Receptores de Lipopolisacáridos/efectos de los fármacos , Receptores de Lipopolisacáridos/genética , Receptores de Lipopolisacáridos/metabolismo , Antígeno 96 de los Linfocitos , Glicoproteínas de Membrana/efectos de los fármacos , Glicoproteínas de Membrana/genética , Ratones , Ratones Transgénicos , FN-kappa B/metabolismo , Osteocalcina/genética , Osteocalcina/metabolismo , Osteoclastos/efectos de los fármacos , Osteoclastos/metabolismo , Osteopontina , Osteoprotegerina , Ligando RANK , ARN Mensajero/análisis , Receptor Activador del Factor Nuclear kappa-B , Receptores de Superficie Celular/efectos de los fármacos , Receptores de Superficie Celular/genética , Receptores Citoplasmáticos y Nucleares/genética , Receptores Citoplasmáticos y Nucleares/metabolismo , Receptores del Factor de Necrosis Tumoral , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Sialoglicoproteínas/genética , Sialoglicoproteínas/metabolismo , Receptor Toll-Like 4 , Receptores Toll-Like , Regulación hacia Arriba/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA